Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study

NCT03777631 is registered in ClinicalTrials.gov with Nippon Medical School as lead sponsor.

NCT NCT03777631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03777631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study
Lead sponsor
Nippon Medical School
Phase
Phase 3
Overall status
Unknown status
Start date
April 1, 2018
Completion date
March 31, 2026
Enrollment
251 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation non-rheumatic, ischemic stroke